DNA Vaccines Industry Research Report 2024

DNA Vaccines Industry Research Report 2024


The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Highlights

The global DNA Vaccines market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Product Type Insights

Global markets are presented by DNA Vaccines type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the DNA Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
DNA Vaccines segment by Type

Recombinant Protein Vaccine
Gene-Based Vaccine

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the DNA Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the DNA Vaccines market.
DNA Vaccines segment by Application
Human
Animal

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the DNA Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the DNA Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DNA Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global DNA Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global DNA Vaccines Sales (2019-2030)
2.2.3 Global DNA Vaccines Market Average Price (2019-2030)
2.3 DNA Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
2.4 DNA Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Human
2.4.3 Animal
3 Market Competitive Landscape by Manufacturers
3.1 Global DNA Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global DNA Vaccines Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global DNA Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global DNA Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global DNA Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of DNA Vaccines, Product Type & Application
3.8 Global Manufacturers of DNA Vaccines, Date of Enter into This Industry
3.9 Global DNA Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck DNA Vaccines Product Portfolio
4.1.5 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK DNA Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi DNA Vaccines Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Zoties
4.4.1 Zoties Company Information
4.4.2 Zoties Business Overview
4.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Zoties DNA Vaccines Product Portfolio
4.4.5 Zoties Recent Developments
4.5 Elanco
4.5.1 Elanco Company Information
4.5.2 Elanco Business Overview
4.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Elanco DNA Vaccines Product Portfolio
4.5.5 Elanco Recent Developments
4.6 Boehringer-Ingelheim
4.6.1 Boehringer-Ingelheim Company Information
4.6.2 Boehringer-Ingelheim Business Overview
4.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
4.6.5 Boehringer-Ingelheim Recent Developments
4.7 Indian Immunologicals
4.7.1 Indian Immunologicals Company Information
4.7.2 Indian Immunologicals Business Overview
4.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
4.7.5 Indian Immunologicals Recent Developments
4.8 Plumbline Life Sciences
4.8.1 Plumbline Life Sciences Company Information
4.8.2 Plumbline Life Sciences Business Overview
4.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
4.8.5 Plumbline Life Sciences Recent Developments
5 Global DNA Vaccines Market Scenario by Region
5.1 Global DNA Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global DNA Vaccines Sales by Region: 2019-2030
5.2.1 Global DNA Vaccines Sales by Region: 2019-2024
5.2.2 Global DNA Vaccines Sales by Region: 2025-2030
5.3 Global DNA Vaccines Revenue by Region: 2019-2030
5.3.1 Global DNA Vaccines Revenue by Region: 2019-2024
5.3.2 Global DNA Vaccines Revenue by Region: 2025-2030
5.4 North America DNA Vaccines Market Facts & Figures by Country
5.4.1 North America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America DNA Vaccines Sales by Country (2019-2030)
5.4.3 North America DNA Vaccines Revenue by Country (2019-2030)
5.4.4 United States
5.4.5 Canada
5.5 Europe DNA Vaccines Market Facts & Figures by Country
5.5.1 Europe DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe DNA Vaccines Sales by Country (2019-2030)
5.5.3 Europe DNA Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific DNA Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific DNA Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific DNA Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 Latin America DNA Vaccines Market Facts & Figures by Country
5.7.1 Latin America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America DNA Vaccines Sales by Country (2019-2030)
5.7.3 Latin America DNA Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa DNA Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa DNA Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global DNA Vaccines Sales by Type (2019-2030)
6.1.1 Global DNA Vaccines Sales by Type (2019-2030) & (K Doses)
6.1.2 Global DNA Vaccines Sales Market Share by Type (2019-2030)
6.2 Global DNA Vaccines Revenue by Type (2019-2030)
6.2.1 Global DNA Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global DNA Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global DNA Vaccines Price by Type (2019-2030)
7 Segment by Application
7.1 Global DNA Vaccines Sales by Application (2019-2030)
7.1.1 Global DNA Vaccines Sales by Application (2019-2030) & (K Doses)
7.1.2 Global DNA Vaccines Sales Market Share by Application (2019-2030)
7.2 Global DNA Vaccines Revenue by Application (2019-2030)
6.2.1 Global DNA Vaccines Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global DNA Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global DNA Vaccines Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 DNA Vaccines Value Chain Analysis
8.1.1 DNA Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 DNA Vaccines Production Mode & Process
8.2 DNA Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 DNA Vaccines Distributors
8.2.3 DNA Vaccines Customers
9 Global DNA Vaccines Analyzing Market Dynamics
9.1 DNA Vaccines Industry Trends
9.2 DNA Vaccines Industry Drivers
9.3 DNA Vaccines Industry Opportunities and Challenges
9.4 DNA Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global DNA Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2019 Versus 2023)
Table 6. Global DNA Vaccines Sales (K Doses) of Manufacturers (2019-2024)
Table 7. Global DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 8. Global DNA Vaccines Revenue of Manufacturers (2019-2024)
Table 9. Global DNA Vaccines Revenue Share by Manufacturers (2019-2024)
Table 10. Global Market DNA Vaccines Average Price (US$/Dose) of Manufacturers (2019-2024)
Table 11. Global DNA Vaccines Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Manufacturers of DNA Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 19. Merck DNA Vaccines Product Portfolio
Table 20. Merck Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 24. GSK DNA Vaccines Product Portfolio
Table 25. GSK Recent Developments
Table 26. Sanofi Company Information
Table 27. Sanofi Business Overview
Table 28. Sanofi DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 29. Sanofi DNA Vaccines Product Portfolio
Table 30. Sanofi Recent Developments
Table 31. Zoties Company Information
Table 32. Zoties Business Overview
Table 33. Zoties DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 34. Zoties DNA Vaccines Product Portfolio
Table 35. Zoties Recent Developments
Table 36. Elanco Company Information
Table 37. Elanco Business Overview
Table 38. Elanco DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 39. Elanco DNA Vaccines Product Portfolio
Table 40. Elanco Recent Developments
Table 41. Boehringer-Ingelheim Company Information
Table 42. Boehringer-Ingelheim Business Overview
Table 43. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 44. Boehringer-Ingelheim DNA Vaccines Product Portfolio
Table 45. Boehringer-Ingelheim Recent Developments
Table 46. Indian Immunologicals Company Information
Table 47. Indian Immunologicals Business Overview
Table 48. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 49. Indian Immunologicals DNA Vaccines Product Portfolio
Table 50. Indian Immunologicals Recent Developments
Table 51. Plumbline Life Sciences Company Information
Table 52. Plumbline Life Sciences Business Overview
Table 53. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 54. Plumbline Life Sciences DNA Vaccines Product Portfolio
Table 55. Plumbline Life Sciences Recent Developments
Table 56. Global DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Global DNA Vaccines Sales by Region (2019-2024) & (K Doses)
Table 58. Global DNA Vaccines Sales Market Share by Region (2019-2024)
Table 59. Global DNA Vaccines Sales by Region (2025-2030) & (K Doses)
Table 60. Global DNA Vaccines Sales Market Share by Region (2025-2030)
Table 61. Global DNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global DNA Vaccines Revenue Market Share by Region (2019-2024)
Table 63. Global DNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 64. Global DNA Vaccines Revenue Market Share by Region (2025-2030)
Table 65. North America DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 66. North America DNA Vaccines Sales by Country (2019-2024) & (K Doses)
Table 67. North America DNA Vaccines Sales by Country (2025-2030) & (K Doses)
Table 68. North America DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 69. North America DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 70. Europe DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe DNA Vaccines Sales by Country (2019-2024) & (K Doses)
Table 72. Europe DNA Vaccines Sales by Country (2025-2030) & (K Doses)
Table 73. Europe DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 75. Asia Pacific DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 76. Asia Pacific DNA Vaccines Sales by Country (2019-2024) & (K Doses)
Table 77. Asia Pacific DNA Vaccines Sales by Country (2025-2030) & (K Doses)
Table 78. Asia Pacific DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 79. Asia Pacific DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 80. Latin America DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 81. Latin America DNA Vaccines Sales by Country (2019-2024) & (K Doses)
Table 82. Latin America DNA Vaccines Sales by Country (2025-2030) & (K Doses)
Table 83. Latin America DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 84. Latin America DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 85. Middle East and Africa DNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 86. Middle East and Africa DNA Vaccines Sales by Country (2019-2024) & (K Doses)
Table 87. Middle East and Africa DNA Vaccines Sales by Country (2025-2030) & (K Doses)
Table 88. Middle East and Africa DNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 89. Middle East and Africa DNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 90. Global DNA Vaccines Sales by Type (2019-2024) & (K Doses)
Table 91. Global DNA Vaccines Sales by Type (2025-2030) & (K Doses)
Table 92. Global DNA Vaccines Sales Market Share by Type (2019-2024)
Table 93. Global DNA Vaccines Sales Market Share by Type (2025-2030)
Table 94. Global DNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 95. Global DNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 96. Global DNA Vaccines Revenue Market Share by Type (2019-2024)
Table 97. Global DNA Vaccines Revenue Market Share by Type (2025-2030)
Table 98. Global DNA Vaccines Price by Type (2019-2024) & (US$/Dose)
Table 99. Global DNA Vaccines Price by Type (2025-2030) & (US$/Dose)
Table 100. Global DNA Vaccines Sales by Application (2019-2024) & (K Doses)
Table 101. Global DNA Vaccines Sales by Application (2025-2030) & (K Doses)
Table 102. Global DNA Vaccines Sales Market Share by Application (2019-2024)
Table 103. Global DNA Vaccines Sales Market Share by Application (2025-2030)
Table 104. Global DNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 105. Global DNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 106. Global DNA Vaccines Revenue Market Share by Application (2019-2024)
Table 107. Global DNA Vaccines Revenue Market Share by Application (2025-2030)
Table 108. Global DNA Vaccines Price by Application (2019-2024) & (US$/Dose)
Table 109. Global DNA Vaccines Price by Application (2025-2030) & (US$/Dose)
Table 110. Key Raw Materials
Table 111. Raw Materials Key Suppliers
Table 112. DNA Vaccines Distributors List
Table 113. DNA Vaccines Customers List
Table 114. DNA Vaccines Industry Trends
Table 115. DNA Vaccines Industry Drivers
Table 116. DNA Vaccines Industry Restraints
Table 117. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. DNA VaccinesProduct Picture
Figure 5. Global DNA Vaccines Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 6. Global DNA Vaccines Market Size (2019-2030) & (US$ Million)
Figure 7. Global DNA Vaccines Sales (2019-2030) & (K Doses)
Figure 8. Global DNA Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 9. Recombinant Protein Vaccine Product Picture
Figure 10. Gene-Based Vaccine Product Picture
Figure 11. Human Product Picture
Figure 12. Animal Product Picture
Figure 13. Global DNA Vaccines Revenue Share by Manufacturers in 2023
Figure 14. Global Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of DNA Vaccines, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2023
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global DNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 19. Global DNA Vaccines Sales by Region in 2023
Figure 20. Global DNA Vaccines Revenue by Region in 2023
Figure 21. North America DNA Vaccines Market Size by Country in 2023
Figure 22. North America DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 23. North America DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 24. United States DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe DNA Vaccines Market Size by Country in 2023
Figure 27. Europe DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific DNA Vaccines Market Size by Country in 2023
Figure 35. Asia Pacific DNA Vaccines Sales Market Share by Country (2019-2030)
Figure 36. Asia Pacific DNA Vaccines Revenue Market Share by Country (2019-2030)
Figure 37. China DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia DNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America DNA Vaccines Market Size by Country in 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings